Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease
about
Endophenotypes in normal brain morphology and Alzheimer's disease: a reviewAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersGenetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunitiesUse of genetic variation as biomarkers for Alzheimer's disease.Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.Genome-wide association studies in Alzheimer's disease: a reviewAssociation between the APOE genotype and psychopathologic symptoms in Alzheimer's diseaseNeuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's DiseaseThe effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's diseasePanel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer diseaseGenetics of Alzheimer's disease in Caribbean Hispanic and African American populations.Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.The influence of ApoE4 on clinical progression of dementia: a meta-analysis.Behavioural genetics of Alzheimer's disease: a comprehensive review.Rapid cognitive decline in Alzheimer's disease: a literature review.Novel susceptibility loci for Alzheimer's disease.Negative symptoms, depression and Alzheimer's disease.Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease.Out of sight out of mind? Support and information given to distant and near relatives of those with dementia.Lack of association between the apolipoprotein E genotype and depression in Alzheimer's disease.HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease.The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.Integrating Omic Technologies in Alzheimer's Disease.
P2860
Q24655973-3CF2B3AC-5A8D-4C50-82B3-C4D0DFB005A6Q26825442-75554567-BEDD-4FC4-B32B-70FD11F7AB4FQ28086879-65B9A5DC-0767-448F-BFEA-95445C474D0CQ33640956-665DA16D-49C9-4614-B5A0-8D3F4A4ABBCDQ34013606-7F52A18F-C592-418A-92A0-846C9C9C18D1Q34364850-AE7374DE-A456-41BF-A66B-38725FED5551Q34530796-2704140E-F47B-469F-A187-DEADBCD6C8A9Q34953672-45E56548-D445-4582-BEBF-6D97BD19C884Q36075642-04787B1D-F556-49A3-8206-B394B7C824D8Q36142817-765E4C96-CCB1-4098-B259-838A9DD7D70EQ36600561-FB567A3F-6384-4BBA-865A-2FB019A50B78Q37178272-D293C036-D3B8-4530-97C1-3A74FC1FA3A9Q37515666-5B90F15A-95D3-4291-B974-72F33DD5218EQ37772498-34813B12-C2D1-479C-8382-888590B19D94Q37789233-6D1922B7-9FB3-4E38-B260-3345E0E17C8DQ37980139-83B1F2D3-0769-4AEB-AB0A-977F826CF1B2Q38178371-35AAD8DC-037E-42B2-BE2A-16F7CAA67BE5Q38801607-D1708A1F-6BFA-469F-8932-2672CBC23B9FQ43982785-ADA8BBA5-7A3E-4B85-838F-320EA5FAE83FQ51918702-54D88276-B5B9-447C-99DC-4E1116A37344Q51953389-D843FE2B-6746-4EA0-A72E-4DBBE3916E9AQ51958182-6B63F699-AAF2-43F4-80F7-C92B964A9520Q53256528-1B6D7A80-6D96-4D31-897D-7AC228F37DB9Q53322019-FFD1730F-6791-4F46-AA85-0B804BED8336Q53392802-2B9E61FE-CE9B-41BF-9E48-C3B717AABD13
P2860
Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Apolipoprotein E: non-cognitiv ...... late onset Alzheimer's disease
@en
type
label
Apolipoprotein E: non-cognitiv ...... late onset Alzheimer's disease
@en
prefLabel
Apolipoprotein E: non-cognitiv ...... late onset Alzheimer's disease
@en
P2093
P2860
P356
P1476
Apolipoprotein E: non-cognitiv ...... late onset Alzheimer's disease
@en
P2093
P2860
P304
P356
10.1136/JNNP.61.6.580
P407
P577
1996-12-01T00:00:00Z